🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07485244
Recruiting Observational

EEG Abnormalities in Adult ICU Patients With High Risk of Delirium

NCT07485244 · tracked via the Priya Life Science USA tracker
Sponsor
Ceribell Inc.
Phase
Observational
Started
2026-04-16
Last updated
2026-04-21

Condition(s) studied

Delirium in the Intensive Care Unit

Investigational drug(s) / intervention(s)

Ceribell EEG System

Ceribell EEG System: EEG will be recorded with the Ceribell EEG System, including headband and recorder.

Study summary

The purpose of this study is to assess the prevalence of EEG abnormalities on Ceribell POC EEG in adult medical, surgical, and cardiovascular ICU patients with high risk of delirium

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Adult patient ≥18 years old * Requiring admission to a medical, surgical and/or cardiovascular ICU for an expected duration ≥ 24 hours * Receiving treatment for shock (e.g., with vasopressors, intra-aortic balloon pump, or Extracorporeal Membrane Oxygenation therapy) and/or respiratory failure \[e.g., on mechanical ventilation or non-invasive positive pressure ventilation (NIPPV)\]. Exclusion Criteria: * Any structural abnormality or head condition, including the presence of a device, that would prevent the use of the Ceribell EEG system for the entire anticipated EEG monitoring period. Examples include: Craniectomy with a missing bone flap in a region where Ceribell EEG electrodes would be placed. * Anticipated use of continuous EEG for a purpose other than delirium detection during the entire expected monitoring period. * Patients who have been on mechanical ventilation for \>72 hours within the current hospitalization or who are on long-term ventilator support prior to the injury that resulted in the current hospitalization. * Expected death within 12 hours of enrollment or lack of commitment to treatment by family or the medical team (e.g., likely to withdraw life support measures within 12 hours of enrollment). * Acute or chronic neurologic deficit precluding CAM-ICU assessments * Inability to understand English * Bilateral Deafness * Blindness that will preclude delirium evaluation * Current enrollment in a study that does not allow co-enrollment * Inability to obtain informed consent * Attending physician refusal * Patient and/or surrogate refusal * Patient unable to consent and no surrogate available * Prisoners

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Vanderbilt University Medical Center Nashville Tennessee Recruiting

More Ceribell Inc. trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07485244 on ClinicalTrials.gov ↗ ← All trials in the USA